Benner joined Masimo in June 2025, initially serving as Chief Marketing and Strategy Officer before moving into the role of Chief Commercial Officer. During his tenure, he navigated the company through the complex transition period following Danaher’s acquisition. Julie Sawyer Montgomery, CEO Designate of Danaher Corporation, cited Benner’s deep customer insight and strategic track record as the primary drivers behind the appointment.
In section Releases
Tim Benner Named President of Masimo
With over three decades of medical technology experience, Tim Benner has been appointed President of Masimo, effective August 3, 2026. The move signals a strategic shift for the diagnostics firm as it integrates further into the Danaher Corporation ecosystem following the recent acquisition.
His career history includes senior leadership positions at industry stalwarts such as Abbott, Edwards Lifesciences, Terumo, and Inari Medical. As President, Benner will oversee Masimo’s global operations, focusing on the expansion of its patient monitoring portfolio and the application of the Danaher Business System to accelerate commercial growth. He replaces the previous leadership focus with a mandate to bridge Masimo’s history of pulse oximetry innovation with the broader diagnostic capabilities of his parent company.
Comments (0)
No comments yet. Be the first!